<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>Insight数据库 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-05T20:12:38+08:00</updated>
  <subtitle>丁香园 Insight 数据库（db.dxy.cn），拥有申报、临床、上市、药企等 10 大核心数据。致力于分享医药行业政策解读、药企大事和药品申报情报等</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>今日 11 款仿制药首家过评，7 款注射剂（附第四批国采最新品规+企业详情）</title>
    <updated>2021-01-05T17:50:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/lZYhwN4yqu9L5vSC2LnWvA</id>
    <link href="https://mp.weixin.qq.com/s/lZYhwN4yqu9L5vSC2LnWvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>权威发布 | 2020 药品审评总结</title>
    <updated>2021-01-05T17:50:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/T9TgA2p0Ob7XTPOPz97jXw</id>
    <link href="https://mp.weixin.qq.com/s/T9TgA2p0Ob7XTPOPz97jXw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞 PD-L1 单抗启动 III 期临床，针对小细胞肺癌</title>
    <updated>2021-01-05T17:50:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/w0ZiFc-1JfuQzG_UIc14YA</id>
    <link href="https://mp.weixin.qq.com/s/w0ZiFc-1JfuQzG_UIc14YA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>复星医药「长效肉毒杆菌毒素」启动 III 期临床，颈部肌张力障碍</title>
    <updated>2021-01-05T17:50:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/XnUBUshuH9fQhjmkxznxeg</id>
    <link href="https://mp.weixin.qq.com/s/XnUBUshuH9fQhjmkxznxeg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正大天晴「安罗替尼」甲状腺癌适应症获批上市</title>
    <updated>2021-01-04T17:15:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/_NtJW6uQk2MUkAm5ldRJvA</id>
    <link href="https://mp.weixin.qq.com/s/_NtJW6uQk2MUkAm5ldRJvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞「阿帕替尼」肝癌新适应症获批上市！CSCO 指南 I 级推荐</title>
    <updated>2021-01-04T17:15:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/b4rAThygcv6yWYyjyknAKQ</id>
    <link href="https://mp.weixin.qq.com/s/b4rAThygcv6yWYyjyknAKQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>默沙东 HIV 新药「多拉韦林拉米夫定替诺福韦片」获批上市！</title>
    <updated>2021-01-04T17:15:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/59glI3zFzqeq6dk7cj6sEA</id>
    <link href="https://mp.weixin.qq.com/s/59glI3zFzqeq6dk7cj6sEA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>北京泰德制药「依托考昔片」获批上市</title>
    <updated>2021-01-04T17:15:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/DalG8DiI9eE2nh57WiEihg</id>
    <link href="https://mp.weixin.qq.com/s/DalG8DiI9eE2nh57WiEihg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 药品审评总结及 2021 药品获批预测</title>
    <updated>2020-12-31T15:30:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/O4dt8ArQo-ZRTxPCZ4vB7w</id>
    <link href="https://mp.weixin.qq.com/s/O4dt8ArQo-ZRTxPCZ4vB7w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>礼来「阿贝西利」获批上市！国内第 2 款 CDK4/6 抑制剂</title>
    <updated>2020-12-31T15:30:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/6VmdbWP2wJ3X4M08Rzfv0Q</id>
    <link href="https://mp.weixin.qq.com/s/6VmdbWP2wJ3X4M08Rzfv0Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！国药集团的新冠疫苗已获批上市</title>
    <updated>2020-12-31T10:24:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/7raZdGdBvIO7pBdyLm91EA</id>
    <link href="https://mp.weixin.qq.com/s/7raZdGdBvIO7pBdyLm91EA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第 33 批「通过一致性评价」名单来了</title>
    <updated>2020-12-31T10:24:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/GwwiHWwnNmmz0zr6PQzmHA</id>
    <link href="https://mp.weixin.qq.com/s/GwwiHWwnNmmz0zr6PQzmHA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021 年，这 15 款新药将在国内获批</title>
    <updated>2020-12-30T17:37:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/zaLV4szv_LQcZBjMiiJ1fQ</id>
    <link href="https://mp.weixin.qq.com/s/zaLV4szv_LQcZBjMiiJ1fQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家短缺药品及监控清单发布！共 63 个药品纳入</title>
    <updated>2020-12-30T17:37:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/CYK22jUDLJaseMSkv_ErzQ</id>
    <link href="https://mp.weixin.qq.com/s/CYK22jUDLJaseMSkv_ErzQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>上海市集采文件发布！3 品种 5 品规纳入</title>
    <updated>2020-12-30T17:37:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/q9lp7UoC4zhrfo5bA9V99Q</id>
    <link href="https://mp.weixin.qq.com/s/q9lp7UoC4zhrfo5bA9V99Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国药集团新冠疫苗 III 期数据：中和抗体转阳率 99.52%</title>
    <updated>2020-12-30T17:37:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/e7g1TBavmGWbOZCMoLeufg</id>
    <link href="https://mp.weixin.qq.com/s/e7g1TBavmGWbOZCMoLeufg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>东阳光改良型新药「磷酸奥司他韦缓释片」申报临床</title>
    <updated>2020-12-30T17:37:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/QYeJPlHsWb9YU1Z_OU_Ikw</id>
    <link href="https://mp.weixin.qq.com/s/QYeJPlHsWb9YU1Z_OU_Ikw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>康方生物 CD47 单抗启动临床</title>
    <updated>2020-12-30T17:37:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/4Ix475hz7vZF_654InRHiA</id>
    <link href="https://mp.weixin.qq.com/s/4Ix475hz7vZF_654InRHiA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今日超 30 款仿制药过评！6 个第四批国采品种，5 个首家过评注射剂</title>
    <updated>2020-12-29T18:46:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/rNocjUf2Wa8igl7OuLoZOQ</id>
    <link href="https://mp.weixin.qq.com/s/rNocjUf2Wa8igl7OuLoZOQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>和黄医药向 FDA 递交「索凡替尼」新药上市申请</title>
    <updated>2020-12-29T18:46:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/DX_kVpfRXAJC2gVx-80njg</id>
    <link href="https://mp.weixin.qq.com/s/DX_kVpfRXAJC2gVx-80njg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>